Terry Gould

Terry Gould is Parnter & Head Of Director Investments of Adams Street Partners， LLC. As Head of Direct Investments， Terry invests in venture and growth-oriented companies in the medical device and biopharma sectors. Terry sits on the Boards of Directors of Incline Therapeutics， Neuraltus， Proteus Biomedical and OncoMed. He is responsible for several other successful investments: CombiChem， Heartport （bought by Johnson and Johnson）， INC Research， Jazz Pharmaceuticals （NASDAQ: JAZZ）， NxStage Medical， Revivant （bought by Zoll）， Spinal Dynamics （bought by Medtronic） and Vivant Medical （bought by Tyco International Ltd.）.

Terry Gould used to work in Brinson Partners/UBS Global Asset Management， Trinity Ventures and Boston Consulting Group. He is the BA of Dartmouth College， and the MBA of Stanford University.